Skip to main content

$17.88 -0.10 (-0.56%)

High

$18.20

Low

$17.50

Trades

1,245

Turnover

$1,190,837

Volume

66,664
30 June 2023 at 4:10pm
Register to track CUV and receive email alerts.
Subject
CUV Ann: Presentation Jefferies London Healthcare Conference

CUV Ann: Results of Meeting

CUV Ann: Managing Director AGM Presentation

CUV Ann: Chair Address

CUV Ann: CLINUVEL Strategic Update III - November 2021

CUV Ann: Media release - CLINUVEL Expands Pharmaceutical Portfolio

CUV Ann: CLINUVEL adds ACTH to portfolio

CUV Ann: Response to ASX Price Query

CUV Ann: Quarterly Activities/Appendix 4C Cash Flow Report

CUV Ann: CLINUVEL Investor Webinar Released

CUV Ann: First Patient Treated in CLINUVEL DNA Repair Study

CUV Ann: Investor Webinar

CUV Ann: Appendix 4G and Corporate Governance Statement

CUV Ann: Notice of Annual General Meeting/Proxy Form

CUV Ann: Annual Report to shareholders

CUV Ann: Operations Update Webcast II

CUV Ann: CLINUVEL Progresses DNA Repair Program

CUV Ann: CLINUVEL Key Events and Announcements

CUV Ann: CLINUVEL Confirms AGM Date

CUV Ann: Notification regarding unquoted securities - CUV

CUV Ann: Presentation H.C. Wainwright Global Investment Conference

CUV Ann: CLINUVEL Investor Webinar Financial Results

CUV Ann: Dividend/Distribution - CUV

CUV Ann: CLINUVEL Newsletter 4 - August 2021

CUV Ann: Corporate Presentation - FY2021 Results

CUV Ann: CLINUVEL Delivers Record Revenues and Profit

CUV Ann: Appendix 4E and Preliminary Financial Report

CUV Ann: Afamelanotide well tolerated by first stroke patients

CUV Ann: Quarterly Activities/Appendix 4C Cash Flow Report

CUV Ann: Change of Director's Interest Notice

CUV Ann: Change of Director's Interest Notice

CUV Ann: Media release - First stroke patient with afamelanotide

CUV Ann: First stroke patient treated with afamelanotide

CUV Ann: CLINUVEL Presentation to Jefferies Healthcare Conference

CUV Ann: CLINUVEL Newsletter 3 - June 2021

CUV Ann: Change of Director's Interest Notice

CUV Ann: Chair's Letter II

CUV Ann: Appendix 4C - quarterly

CUV Ann: CLINUVEL Strategic Update II - April 2021

CUV Ann: CLINUVEL Newsletter II - April 2021

CUV Ann: Chair's Letter I

CUV Ann: Media Release - CLINUVEL expands DNA Repair Program

CUV Ann: SCENESSE to be assessed in xeroderma pigmentosum variant XPV

CUV Ann: Presentation - Daiwa Investment Conference Tokyo 2021

CUV Ann: Change of Director's Interest Notice

CUV Ann: Change of Director's Interest Notice

CUV Ann: Operations Update Webinar Released

CUV Ann: CLINUVEL Reports Tenth Consecutive Half Year Profit

CUV Ann: Appendix 4D Half Yearly Report

CUV Ann: Financial Results Half Year - Webinar Announcement

Register to track CUV and receive email alerts.

Similar Companies

CSL ...
CSL
IMM
IMU
MSB
OPT
PAR
PYC
RAC
TLX